Matthew R Burns, MD, PhD
Assistant Professor of Neurology
Department:
MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone:
(352) 294-5000
Business Email:
mburns1@ufl.edu
About Matthew R Burns
My name is Matthew Burns, MD, PhD, and I am a board-certified neurologist and movement disorders specialist at the Norman Fixel Institute for Neurological Diseases at UF Health, serving as an assistant professor in the University of Florida Department of Neurology.
I received my medical and doctorate degrees from the University of Illinois College of Medicine at Chicago in 2012. I went on and completed my neurology residency at the University of Chicago Medical Center in 2018 and my movement disorders fellowship at UF in 2021.
In clinic, I see patients for a variety of movement disorders including dystonia, tremor disorders and ataxia. When I’m not seeing patients in clinic, I run a National Institutes of Health-funded lab focused on the non-motor symptoms of neurodegenerative disorders, the molecular mechanisms of aging and neuromodulation.
As a clinician and a researcher, I aim to translate my knowledge of the molecular mechanisms of neurodegenerative disease, high-field imaging, brain machine interface and electrophysiology into therapies for patients who have movement disorders and dementia.
In my free time, I enjoy exercising, playing piano and helping coach my kids’ little league teams.
Related Links:
Teaching Profile
Courses Taught
2022
MDU4002 Introduction to Medical Science Seminar 2
2022-2023
PAS5020 Intro to Medicine 2
2022-2023
GMS6905 Independent Studies in Medical Sciences
2023-2024
GMS6090 Research in Medical Sciences
2024-2025
GMS6971 Research for Master’s Thesis
Board Certifications
-
NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Neurology
Areas of Interest
- Acute Cerebellar Ataxia
- Ataxia
- Deep Brain Stimulation
- Dystonia
- Essential Tremor
- Friedreich Ataxia
- Movement – Uncontrollable
- Movement – Uncontrolled or Slow
- Movement – Uncoordinated
- Movement – Unpredictable or Jerky
- Parkinson Disease
- Tremor disorders
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-9309-7723
Areas of Interest
- Deep brain stimulation
- Dementia
- Electrophysiology
- Neurodegenerative diseases
- ataxia
- mechanisms of aging
- neuromodulatory treatments
Publications
Academic Articles
2025
A Convergent Pathway for Stimulation-Induced Dyskinesia Following Deep Brain Stimulation.
Movement disorders : official journal of the Movement Disorder Society.
[DOI] 10.1002/mds.30251.
[PMID] 40443125.
2025
Emerging therapies in hereditary ataxias.
Trends in molecular medicine.
31(2):181-194
[DOI] 10.1016/j.molmed.2024.07.008.
[PMID] 39153956.
2025
Suicidal Ideation in Spinocerebellar Ataxia.
The Journal of neuropsychiatry and clinical neurosciences.
[DOI] 10.1176/appi.neuropsych.20250006.
[PMID] 40350965.
2024
Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias.
Movement disorders clinical practice.
11(5):496-503
[DOI] 10.1002/mdc3.14006.
[PMID] 38419568.
2024
Pictures at an exhibition: A commentary on Benn & Robinson (2024).
Cognitive, affective & behavioral neuroscience.
24(2):368-369
[DOI] 10.3758/s13415-024-01174-z.
[PMID] 38472614.
2022
Evolving Concepts in Our Understanding and Treatment of Holmes Tremor, Over 100 Years in the Making
Tremor and Other Hyperkinetic Movements.
12(1)
[DOI] 10.5334/tohm.683.
[PMID] 35651920.
2022
Inherited Ataxias in Children.
Pediatric neurology.
131:54-62
[DOI] 10.1016/j.pediatrneurol.2022.04.004.
[PMID] 35490578.
2022
Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease.
Brain communications.
4(4)
[DOI] 10.1093/braincomms/fcac165.
[PMID] 35822101.
2022
TANGO2 Mutation: A Genetic Cause of Multifocal Combined Dystonia.
Movement disorders clinical practice.
9(3):380-382
[DOI] 10.1002/mdc3.13400.
[PMID] 35402644.
2021
Advances and Future Directions of Neuromodulation in Neurologic Disorders.
Neurologic clinics.
39(1):71-85
[DOI] 10.1016/j.ncl.2020.09.004.
[PMID] 33223090.
2021
An Update on Botulinum Toxin in Neurology.
Neurologic clinics.
39(1):209-229
[DOI] 10.1016/j.ncl.2020.09.014.
[PMID] 33223084.
2021
Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology
Expert Review of Medical Devices.
18(9):875-891
[DOI] 10.1080/17434440.2021.1962286.
2021
Disparities in diagnosis, treatment and survival between Black and White Parkinson patients
Parkinsonism & Related Disorders.
87:7-12
[DOI] 10.1016/j.parkreldis.2021.04.013.
2020
Co-occurrence of apathy and impulse control disorders in Parkinson disease.
Neurology.
95(20):e2769-e2780
[DOI] 10.1212/WNL.0000000000010965.
[PMID] 33004605.
2020
Current Management and Emerging Therapies in Multiple System Atrophy.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
17(4):1582-1602
[DOI] 10.1007/s13311-020-00890-x.
[PMID] 32767032.
2020
Deep Brain Stimulation Impedance Decreases Over Time Even When Stimulation Settings Are Held Constant.
Frontiers in human neuroscience.
14
[DOI] 10.3389/fnhum.2020.584005.
[PMID] 33240066.
2020
Functional and Structural Connectivity Patterns Associated with Clinical Outcomes in Deep Brain Stimulation of the Globus Pallidus Internus for Generalized Dystonia
American Journal of Neuroradiology.
41(3):508-514
[DOI] 10.3174/ajnr.a6429.
2020
High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy.
Tremor and other hyperkinetic movements (New York, N.Y.).
10
[DOI] 10.7916/tohm.v0.749.
[PMID] 32149014.
2020
Neuroimaging Advances in Deep Brain Stimulation: Review of Indications, Anatomy, and Brain Connectomics
American Journal of Neuroradiology.
41(9):1558-1568
[DOI] 10.3174/ajnr.a6693.
2020
Using rodent models to understand interactions between gambling and substance use.
Current opinion in behavioral sciences.
31:37-41
[DOI] 10.1016/j.cobeha.2019.10.012.
[PMID] 33102640.
2019
Dorsal GPi/GPe Stimulation Induced Dyskinesia in a Patient with Parkinson’s Disease.
Tremor and other hyperkinetic movements (New York, N.Y.).
9
[DOI] 10.7916/tohm.v0.685.
[PMID] 31565536.
2015
Calcinosis cutis presenting in the context of long-term therapy for chronic myeloid leukemia: a case report and review of the literature.
Wounds : a compendium of clinical research and practice.
27(2):20-5
[PMID] 25785904.
2011
Microtubule-severing ATPase spastin in glioblastoma: increased expression in human glioblastoma cell lines and inverse roles in cell motility and proliferation.
Journal of neuropathology and experimental neurology.
70(9):811-26
[DOI] 10.1097/NEN.0b013e31822c256d.
[PMID] 21865889.
Grants
Apr 2024
ACTIVE
Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias
Role: Project Manager
Funding: US ARMY MED RES ACQUISITION
Mar 2023
– Apr 2024
Cognito Master Student Salary Support (Neuroscience)
Role: Principal Investigator
Funding: COGNITO THERAPEUTICS
Mar 2022
– Feb 2023
Assessment of diffusion imaging metrics in cerebellar tracts as a quantitative marker of disease progression in SCA
Role: Principal Investigator
Funding: NATL ATAXIA FOUNDATION
Jul 2021
ACTIVE
Contribution of RAN proteins to HD, SCA3 other CAG.CTG expansion diseases
Role: Project Manager
Funding: NATL INST OF HLTH NINDS
Jul 2021
– Feb 2023
Cognitive and Motivational Network Dysfunction & Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2021
– Dec 2022
Cognitive and Motivational Network Dysfunction & Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2021
– Jul 2021
Optogenetic Modulation of Mesocorticolimbic Brain Networks as a Treatment for Parkinsons Disease Cognitive Dysfunction
Role: Principal Investigator
Funding: AMER ACAD OF NEUROLOGY
May 2021
ACTIVE
Cognitive and Affective Network Dysfunction and Neuromodulation in Aging and Synucleinopathy
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
Jan 2020
– Jun 2021
Modulation of Synuclein Pathology Through Induction of Gamma Band Oscillations in a Mouse Model of DLB
Role: Principal Investigator
Funding: UF FOUNDATION
Jun 2019
– May 2021
DRPD-ROF2019: A Microfluidics Optrode: A Next Generation Approach to Brain Network Modulation in Parkinsons Disease
Role: Principal Investigator
Funding: UF RESEARCH
Dec 2016
ACTIVE
Clinical Research Consortium for the Study of Cerebellar Ataxias activities
Role: Principal Investigator
Funding: NATL ATAXIA FOUNDATION
Education
Fellowship, Movement Disorders
2018
·
University of Florida
Residency, Neurology
2015-2018
·
University of Chicago Medical Center
Doctorate Degree, Philosophy and Neuroscience
2007-2012
·
University of Illinois College of Medicine at Chicago
Medical Degree
2005-2012
·
University of Illinois College of Medicine at Chicago
Bachelor of Arts, Physics and Religion
1996-2001
·
Oberlin College
Contact Details
Phones:
- Business:
- (352) 294-5000
Emails:
- Business:
- mburns1@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100236
GAINESVILLE IL 32610 - Business Street:
-
1149 NEWELL DR RM L2 # 140
GAINESVILLE FL 32610